3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Carcinoma, Non-Small-Cell Lung
73
Lung Neoplasms
64
Breast Neoplasms
63
Lymphoma
58
Ovarian Neoplasms
51
Leukemia
44
Sarcoma
43
Prostatic Neoplasms
39
Multiple Myeloma
36
Head and Neck Neoplasms
36
Central Nervous System Neoplasms
36
Squamous Cell Carcinoma of Head and Neck
32
Colorectal Neoplasms
31
Carcinoma, Ovarian Epithelial
30
Melanoma
29
Rectal Neoplasms
28
Neoplasm Metastasis
27
Uterine Cervical Neoplasms
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Lymphoma, Large B-Cell, Diffuse
26
Brain Neoplasms
26
Urinary Bladder Neoplasms
24
Leukemia, Lymphocytic, Chronic, B-Cell
24
Leukemia, Myeloid, Acute
23
Fallopian Tube Neoplasms
23
Endometrial Neoplasms
22
Glioblastoma
21
Adenocarcinoma of Lung
21
Lymphoma, Mantle-Cell
18
Gliosarcoma
17
Interventions
Medical Marijuana
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
NETWORK
×
Brain Injuries, Traumatic
×
Clear all
NCT03944447
2022-06-02
OMNI-Can
OMNI Medical Services, LLC
Phase 2
Unknown
200,000 enrolled